Showing results (321-330 of 3,538) with videos related to
Sort By:
Pageof 354
Chemical Biology & Drug Design|March 18, 2009
Discovery and binding studies on a series of novel Pin1 ligandsBainan Wu, Michele F Rega, Jun Wei, et al.Chemical Biology & Drug Design|March 18, 2009
Rational design of multitargeted tyrosine kinase inhibitors: a novel approachSylvie Barchéchath, Christopher Williams, Khalil Saade, et al.Chemical Biology & Drug Design|March 18, 2009
Dye labelling of nucleosidesAlan R Katritzky, Levan Khelashvili, Judit Kovacs, et al.Chemical Biology & Drug Design|March 18, 2009
Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agentsPonnurengam Malliappan Sivakumar, Sobana Priya, Mukesh DobleChemical Biology & Drug Design|February 27, 2009
Quantitative structure-activity relationship models with receptor-dependent descriptors for predicting peroxisome proliferator-activated receptor activities of thiazolidinedione and oxazolidinedione derivativesViney Lather, Visvaldas Kairys, Miguel X FernandesChemical Biology & Drug Design|December 19, 2008
Effect of a novel series of benzothiazolo-quinazolones on epidermal growth factor receptor (EGFR) and biological evaluationsGauri Shukla, Anjani K Tiwari, Vinay K Singh, et al.Chemical Biology & Drug Design|December 19, 2008
Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screeningJinyoung Kim, Ki-sun Kim, Dong-Eun Kim, et al.Chemical Biology & Drug Design|December 19, 2008
Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activityYasemin G Işgör, Zuhal Kiliç, Süreyya OlgenChemical Biology & Drug Design|October 11, 2008
Development of a new pharmacophore model that discriminates active compstatin analogsTing-Lan Chiu, Chandrika Mulakala, John D Lambris, et al.Chemical Biology & Drug Design|October 11, 2008
Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitorsNeelam Seedher, Sonu Bhatia, Bhupinder SinghPageof 354